Anti-vascular Endothelial Growth Factor Pharmacotherapy in the Treatment of Subretinal Choroidal Neovascularization
نویسنده
چکیده
© T O U C H B R I E F I N G S 2 0 1 2 Intravitreal anti-vascular endothelial growth factor (VEGF) pharmacotherapy, introduced in 2004, has evolved over the last decade to revolutionize the treatment of patients suffering from subretinal choroidal neovascularization (CNV). Anti-VEGF agents, which are readily available today, are much better, more potent, and longer acting in comparison with previous treatment modalities, and therefore have dramatically improved the prognosis of patients with CNV.
منابع مشابه
Swept-source optical coherence tomography angiography for choroidal neovascularization after bevacizumab and photodynamic therapy
Purpose To report the swept-source optical coherence tomography angiography (SS-OCTA) findings after bevacizumab anti-vascular endothelial growth factor (anti-VEGF) and full-fluence photodynamic therapy (PDT) for choroidal neovascularization. Design Case report. Methods An 87-year-old, Chinese male presented with a shadow and decreased vision to 20/160 in his left eye (OS). Clinical examina...
متن کاملIntravitreal ranibizumab and bevacizumab therapy for choroidal neovascularization in age-related macular degeneration with extensive pre-existing geographic atrophy.
PURPOSE To report the response of choroidal neovascularization to intravitreal ranibizumab or bevacizumab treatment in the setting of age-related macular degeneration with extensive pre-existing geographic atrophy of the retinal pigment epithelium. METHODS This is a retrospective case series of 11 eyes in ten consecutive patients retrieved from a photographic database. The patients were treat...
متن کاملUpdate on Advances in Polypoidal Choroidal Vasculopathy - A Subtype of Subretinal Neovascularization
Polypoidal choroidal vasculopathy (PCV) is a subtype of subretinal neovascularization and a variant of agerelated macular degeneration. Recent advances in diagnosis and treatment of this disease entity have improved the management of PCV and its outcomes. The diagnosis of PCV is often made based on funduscopic findings, but more definitively on indocyanine green angiography (ICGA) patterns. OCT...
متن کاملInhibition of Placenta Growth Factor Reduces Subretinal Mononuclear Phagocyte Accumulation in Choroidal Neovascularization.
Purpose The cellular immune response driven by mononuclear phagocytes (MPs) is crucial for choroidal neovascularization (CNV) progression. Case reports show that a switch from pure anti-vascular endothelial growth factor-A (VEGF-A) intravitreal treatment to aflibercept, a drug with combined anti-VEGF-A and anti-placenta growth factor (PlGF) activity, can be beneficial for patients who do not re...
متن کاملReal Life Clinical Effectiveness of Razumab® (World’s First Biosimilar Ranibizumab) in Wet Age-Related Macular Degeneration: A Subgroup Analysis of Pooled Retrospective RE-ENACT Study
Wet age-related macular degeneration (wet AMD), a leading cause of vision loss globally, is a late-onset, multifactorial retinal degenerative disease. The characteristic features of wet AMD are neovascularization originating from the choroidal vasculature and spreading to the subretinal pigment epithelium or subretinal space, and increased intraretinal (IRF) or subretinal fluid (SRF) [1-4]. The...
متن کامل